Related Experiment Videos
Long-term epidural pain relief using a totally implantable access system.
J Denobile1, W Chester, H B Etienne
1Department of Surgery, National Naval Medical Center, Bethesda, MD 20814.
Journal of Surgical Oncology
|February 1, 1990
Summary
Terminal cancer patients often suffer severe pain, with inadequate relief for many. This study explores epidural catheters and implantable systems for effective pain management, showing promising results in morphine delivery and catheter longevity.
Area of Science:
- Oncology
- Pain Management
- Neurosurgery
Background:
- Cancer pain significantly impacts quality of life in terminal patients.
- Less than 60% of patients achieve adequate pain relief with current methods.
- Advanced pain management strategies are crucial for palliative care.
Purpose of the Study:
- To evaluate the efficacy of epidural catheters connected to implantable access systems for pain relief in terminal cancer patients.
- To determine the required dosage of morphine for effective pain control.
- To assess the functional duration of the implanted epidural catheters.
Main Methods:
- Epidural catheters were surgically placed and connected to implantable access systems.
- Patients received continuous epidural morphine infusion with occasional boluses.
- Morphine dosage, catheter patency, and patient-reported pain levels were monitored.
Main Results:
- Patients required an average of 0.4-3.5 mg of morphine per hour.
- Catheter lifespan varied significantly, ranging from 15 to 157 days.
- The average catheter lifespan was recorded as 57 days, indicating a need for potential revisions or maintenance.
Conclusions:
- Epidural catheters with implantable systems offer a viable method for managing severe cancer pain.
- Optimized morphine delivery via these systems can improve patient comfort.
- Further research into long-term device function and patient outcomes is warranted.